Emergent BioSolutions Inc. (EBS)
NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
As of 12:47PM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 208.56M |
| Enterprise Value | 1.04B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.18 |
| Price/Book (mrq) | 0.31 |
| Enterprise Value/Revenue | 0.90 |
| Enterprise Value/EBITDA | -3.00 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.19 |
| 52-Week Change 3 | -58.97% |
| S&P500 52-Week Change 3 | 25.77% |
| 52 Week High 3 | 10.8800 |
| 52 Week Low 3 | 1.4200 |
| 50-Day Moving Average 3 | 2.5070 |
| 200-Day Moving Average 3 | 3.0025 |
Share Statistics
| Avg Vol (3 month) 3 | 5.97M |
| Avg Vol (10 day) 3 | 18.84M |
| Shares Outstanding 5 | 52.4M |
| Implied Shares Outstanding 6 | 52.39M |
| Float 8 | 51.7M |
| % Held by Insiders 1 | 1.88% |
| % Held by Institutions 1 | 78.57% |
| Shares Short (Apr 15, 2024) 4 | 5.89M |
| Short Ratio (Apr 15, 2024) 4 | 4.76 |
| Short % of Float (Apr 15, 2024) 4 | 13.77% |
| Short % of Shares Outstanding (Apr 15, 2024) 4 | 11.25% |
| Shares Short (prior month Mar 15, 2024) 4 | 4.91M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Mar 31, 2024 |
Profitability
| Profit Margin | -47.69% |
| Operating Margin (ttm) | 13.25% |
Management Effectiveness
| Return on Assets (ttm) | -0.38% |
| Return on Equity (ttm) | -60.57% |
Income Statement
| Revenue (ttm) | 1.19B |
| Revenue Per Share (ttm) | 22.93 |
| Quarterly Revenue Growth (yoy) | 82.80% |
| Gross Profit (ttm) | N/A |
| EBITDA | 100.2M |
| Net Income Avi to Common (ttm) | -565.3M |
| Diluted EPS (ttm) | -10.9700 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 78.5M |
| Total Cash Per Share (mrq) | 1.5 |
| Total Debt (mrq) | 922.2M |
| Total Debt/Equity (mrq) | 138.91% |
| Current Ratio (mrq) | 1.08 |
| Book Value Per Share (mrq) | 12.67 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -84.9M |
| Levered Free Cash Flow (ttm) | 133.66M |
© 2024 Yahoo. All rights reserved.